Salestools LogoSalestools
Agenti IA Salestools
Soluzioni
Risorse
Azienda
Prezzi
Salestools Logo

Salestools

L'agente IA #1 per team di vendita e Go-to-Market. Vendi di più, più velocemente, con meno sforzo.

Prodotto

  • Agenti di vendita IA
  • Dati di intenzione
  • Dati Tecnologici
  • Tracciamento Visitatori
  • Co-Pilota
  • Vendita Sociale

Soluzioni

  • Servizio Clienti
  • E-commerce
  • SaaS
  • Impresa
  • Piccole Imprese

Risorse

  • Il rapporto
  • Documentazione
  • Riferimento API
  • Centro assistenza
  • Blog
  • Casi studio
  • Webinar

Azienda

  • Chi siamo
  • Carriere
  • Stampa
  • Contatto
  • Partner

Le nostre sedi

  • New York, HQ
  • Bucarest, Laboratorio di Ricerca IA
  • Zug, Svizzera

© 2025 Salestools. Tutti i diritti riservati.

Termini sui Dati e SicurezzaPolitica sulla privacyTermini di servizio
Tutti i sistemi operativi
Salestools LogoSalestools
Agenti IA Salestools
Soluzioni
Risorse
Azienda
Prezzi
Back to The Report
Fundraising

Covariant

Covariant Raises $75M in Series D

2017
Founded
120+
Employees
Berkeley, CA
Updated May 16, 2024
2 min read

Quick Facts

Covariant Raises $75M in Series D


Covariant has successfully raised $75M in a Series D at a $625M valuation led by Index Ventures, Radical Ventures.


Company Overview


Covariant is a Robotics company headquartered in Berkeley, CA, founded in 2017 with 120+ employees.


AI robotics platform for warehouse automation and pick-and-place operations


Fundraising Details


  • Amount Raised: $75M
  • Round Type: Series D
  • Valuation: $625M
  • Date: 2024-05-16
  • Investors: Index Ventures, Radical Ventures

About Covariant


AI robotics platform for warehouse automation and pick-and-place operations The company is positioned in the Robotics sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: Berkeley, CA
  • Founded: 2017
  • Team Size: 120+
  • Industry: Robotics

What This Means


This funding round demonstrates strong investor confidence in Covariant's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The Robotics sector continues to attract significant investment as companies innovate to meet evolving market demands. Covariant's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $625M valuation marks an important milestone for Covariant, positioning the company among notable players in the Robotics industry.


Looking Ahead


With this new capital, Covariant is well-positioned to execute on its growth strategy and continue building innovative solutions in the Robotics space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2024-05-16. For more information about Covariant, visit their headquarters at Berkeley, CA.

Topics

Fundraising(2912)Robotics(305)Series DCovariant

About the Author

Fundraising News Team
Fundraising News Team
Tracking the latest funding rounds and investment news

Related Company Reports

Fundraising
Harvey AI

Harvey AI Raises $160 million in Series F

Harvey AI, a AI Software company based in San Francisco CA, has raised $160 million in Series F at a $8 billion valuation led by Andreessen Horowitz.

Market Intelligence Team
Market Intelligence Team
Dec 4, 2025
0 min read•160 million
Fundraising
7AI

7AI Raises $130 million in Series A

7AI, a Cybersecurity company based in Boston MA, has raised $130 million in Series A at a $700 million valuation led by Index Ventures.

Market Intelligence Team
Market Intelligence Team
Dec 4, 2025
0 min read•130 million
Fundraising
TRIANA Biomedicines

TRIANA Biomedicines Raises $120 million in Series B

TRIANA Biomedicines, a Biotechnology company based in Lexington MA, has raised $120 million in Series B at a Undisclosed led by Ascenta Capital.

Market Intelligence Team
Market Intelligence Team
Dec 3, 2025
0 min read•120 million